Literature DB >> 33819753

Diverse contributions of avidity to the broad neutralization of Dengue virus by antibodies targeting the E dimer epitope.

Jennifer L Remmel1, Julia C Frei2, Savannah E Butler3, Jonathan R Lai2, Margaret E Ackerman4.   

Abstract

Antibodies (Abs) recognizing the Dengue virus (DENV) E dimer epitope (EDE) that potently neutralize all DENV serotypes are promising templates for vaccine design. As an important feature for some Abs is their bivalency, we sought to define the role avidity plays in neutralization by EDE Abs. We compared neutralization activity between bivalent IgGs and monovalent Ab fragments (Fabs) for two EDE Abs, A11 and C10. IgG forms of both Abs exhibited more potent neutralization activity than their counterpart Fabs, yet only for C10 was this enhanced activity associated with bivalent binding. A11 and C10 also exhibited differential binding profiles to DENV virus-like particles under acidic conditions mimicking the environment that triggers viral membrane fusion, suggesting that EDE Abs employ diverse neutralization mechanisms despite sharing an epitope. Delineating the full range of Ab binding modes and neutralization mechanisms against a single epitope may inform therapeutic approaches and refine vaccine design.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody valency; Broadly neutralizing antibodies; Dengue virus; E dimer epitope; Virus neutralization

Mesh:

Substances:

Year:  2021        PMID: 33819753      PMCID: PMC8205970          DOI: 10.1016/j.virol.2021.03.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.513


  39 in total

1.  Distribution and three-dimensional structure of AIDS virus envelope spikes.

Authors:  Ping Zhu; Jun Liu; Julian Bess; Elena Chertova; Jeffrey D Lifson; Henry Grisé; Gilad A Ofek; Kenneth A Taylor; Kenneth H Roux
Journal:  Nature       Date:  2006-05-24       Impact factor: 49.962

Review 2.  Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

3.  The Fc valency of an immune complex is the decisive factor for binding to low-affinity Fc gamma receptors.

Authors:  R J Klaassen; R Goldschmeding; P A Tetteroo; A E Von dem Borne
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

4.  Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Authors:  James D Brien; S Kyle Austin; Soila Sukupolvi-Petty; Katie M O'Brien; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

5.  Structure of the dengue virus envelope protein after membrane fusion.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

6.  Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.

Authors:  Stylianos Bournazos; Anna Gazumyan; Michael S Seaman; Michel C Nussenzweig; Jeffrey V Ravetch
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

7.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses.

Authors:  Alexander Rouvinski; Pablo Guardado-Calvo; Giovanna Barba-Spaeth; Stéphane Duquerroy; Marie-Christine Vaney; Carlos M Kikuti; M Erika Navarro Sanchez; Wanwisa Dejnirattisai; Wiyada Wongwiwat; Ahmed Haouz; Christine Girard-Blanc; Stéphane Petres; William E Shepard; Philippe Desprès; Fernando Arenzana-Seisdedos; Philippe Dussart; Juthathip Mongkolsapaya; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2015-01-12       Impact factor: 49.962

8.  Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.

Authors:  Pei-Gang Wang; Mateusz Kudelko; Joanne Lo; Lewis Yu Lam Siu; Kevin Tsz Hin Kwok; Martin Sachse; John M Nicholls; Roberto Bruzzone; Ralf M Altmeyer; Béatrice Nal
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

9.  Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.

Authors:  Melissa A Edeling; S Kyle Austin; Bimmi Shrestha; Kimberly A Dowd; Swati Mukherjee; Christopher A Nelson; Syd Johnson; Manu N Mabila; Elizabeth A Christian; Joseph Rucker; Theodore C Pierson; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2014-04-17       Impact factor: 6.823

10.  Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen.

Authors:  Jennifer I Lai; Deeptak Verma; Chris Bailey-Kellogg; Margaret E Ackerman
Journal:  Protein Eng Des Sel       Date:  2018-04-01       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.